Sihuan Pharmaceutical Holdings Group Ltd. 0460

HKEX · Hong Kong SAR China · Health Technology

HKD 0.7200-0.01 (-1.37%)

Market closed· Oct 2, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Sihuan Pharmaceutical Holdings Group Ltd. 0460

HKEX · Hong Kong SAR China · Health Technology

HKD 0.7200-0.01 (-1.37%)

Market closed· Oct 2, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-48.94% · 6MFull-screen chart

Open HKD 0.7200High HKD 0.7250Low HKD 0.6850Close HKD 0.7200Volume 10.43M

Oct 2, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: HKD 0.7300
Day range: HKD 0.6850 – HKD 0.7250
52-week range: HKD 0.6850 – HKD 1.92
Volume: 10.43M
Market cap: HKD 6.81B
P/E (last fiscal year): 32.8
Dividend yield (annualized): 2.99%
Next earnings date: 2027-04-01
Avg. volume (1Y): 32.08M

Performance

1 week

0.00%

1 month

-6.49%

3 months

-20.88%

6 months

-49.38%

Year to date

-43.05%

1 year

-58.35%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Other
Country: Hong Kong SAR China
Exchange: HKEX
Shares outstanding: 9.00B
Employees: 2,843
ISIN: BMG8162K1137
Beta: 1.07

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceAug 08, 2026

Sihuan Pharmaceutical Holdings Group (SEHK:460) Following Profit Guidance Why Valuation Still Looks Pricey

Sihuan Pharmaceutical Holdings Group (SEHK:460) issued new earnings guidance for the first half of 2026, indicating a significant increase in net profit on stable revenue, supported by medical aesthetics, drug commercialization, associate profits and asset divestments. See our latest analysis for Sihuan Pharmaceutical Holdings Group. Sihuan Pharmaceutical Holdings Group’s recent earnings guidance comes after a mixed period for investors. The share price is at HK$0.905, with a 90 day share...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.